Sistema Binnopharm Group's export revenue in 2024 reached ₽3.8 billion. The main contribution to this growth was made by key markets - Kazakhstan, Kyrgyzstan and Uzbekistan, where the volume of supplies increased by 30%. This was possible due to successful registration of new drugs and portfolio expansion, as well as active promotion and interaction with the medical...